SCHEMBL737783

SCHEMBL737783

Cc1ccc2[nH]c(=O)n(CCN3CCOCC3)c2n1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTDSP1 Q9GZU7 1/20 0.53
GAA P10253 1/20 0.49
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TLR9 Q9NR96 3/20 0.47
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
POLB P06746 2/20 0.45
USP2 O75604 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
IMPDH2 P12268 1/20 0.44
TLR7 Q9NYK1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11230940 0.79 CTDSP1 (0.46) CTDSP1GAALMNAKDM4EHTT
SCHEMBL737292 0.77 DAO (0.49) CTDSP1GAAKDM4EHSD17B10TLR9
SCHEMBL21285531 0.77 CYP1A2 (0.49) GAALMNAKDM4EHTTHSD17B10
SCHEMBL738116 0.76 CHRM2 (0.51) CTDSP1LMNAKDM4EHTTHSD17B10
SCHEMBL8349922 0.74 HTR7 (0.50) LMNAKDM4EHTTHSD17B10ALDH1A1
SCHEMBL737401 0.74 DAO (0.48) CTDSP1GAAALDH1A1MEN1KMT2A
SCHEMBL34462160 0.73 TLR7 (0.63) CTDSP1ALDH1A1TLR7
SCHEMBL739228 0.72 HTR7 (0.73) LMNAHTTALDH1A1MEN1KMT2A
SCHEMBL2268013 0.72 KDM4E (0.59) GAALMNAKDM4EALDH1A1MEN1
Hydrochloric Acid SCHEMBL9725420 0.71 HTR7 (0.71) LMNAHTTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138177-B2 Benzimidazolone derivatives as CB2 receptor ligands PFIZER INC. (US) 2012-03-20 US disclosed
EP-1861377-B1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS PFIZER (US) 2010-12-29 EP disclosed
US-20090298811-A1 BENZIMIDAZOLONE DERIVATIVES PFIZER INC 2009-12-03 US disclosed
US-20090181957-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS ANDO KAZUO 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298811-A1 BENZIMIDAZOLONE DERIVATIVES TRPV1, CNR1, CNR2 CTDSP1 2735/4885GAA 2302/4885LMNA 1555/4885
US-20090181957-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS TRPV1, CNR1, CNR2 CTDSP1 3426/4885GAA 3568/4885LMNA 1856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.